
Can Agilent Technologies' (A) AI Moves Redefine Its Edge in Diagnostics and Security Markets?

I'm PortAI, I can summarize articles.
Agilent Technologies has launched its Insight Series Alarm Resolution Systems for airport security and partnered with Lunit for AI-driven companion diagnostics, expanding its presence in biopharma and security markets. Despite growth opportunities, supply chain issues and tariff costs pose risks to profitability. Projections indicate Agilent could reach $8 billion in revenue and $1.7 billion in earnings by 2028, with fair value estimates ranging from $108.23 to $138.83 per share. Investors are encouraged to consider multiple perspectives before making decisions.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

